Home
PFE
PFE News

Latest Pfizer Inc. (PFE) News on June 2, 2025

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal

Bloomberg

3 hours ago

Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal

MT Newswires

4 hours ago

Arvinas, Pfizer Report Breast Cancer Treatment Phase 3 Trial Results; Arvinas Shares Down Pre-Bell

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)

StockStory

12 hours ago

Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE)

Terrible News for Pfizer Stock Investors

Motley Fool

a day ago

Terrible News for Pfizer Stock Investors

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

GlobeNewswire

2 days ago

Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer

Full Arvinas, Pfizer data confirm potential, limits of ‘Protac’ drug in breast cancer

BioPharma Dive

2 days ago

Full Arvinas, Pfizer data confirm potential, limits of ‘Protac’ drug in breast cancer

Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%

Benzinga

3 days ago

Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50%

ASCO25: Pfizer’s Braftovi combo boasts 47% drop in disease progression in mCRC

Pharmaceutical Technology

3 days ago

ASCO25: Pfizer’s Braftovi combo boasts 47% drop in disease progression in mCRC

MT Newswires

3 days ago

Pfizer Says Braftovi Combination Regimen Halved Death Risk in Colorectal Cancer Study

Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Business Wire

3 days ago

Pfizer’s BRAFTOVI® Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer

Pfizer Inc. (PFE) Ends Acepodia Partnership Amid Depo-Provera Legal Woes

Insider Monkey

4 days ago

Pfizer Inc. (PFE) Ends Acepodia Partnership Amid Depo-Provera Legal Woes

Pfizer (NYSE:PFE) Ends Collaboration With Acepodia And Faces Depo-Provera Legal Challenges

Simply Wall St.

4 days ago

Pfizer (NYSE:PFE) Ends Collaboration With Acepodia And Faces Depo-Provera Legal Challenges

PFE or LLY: Which Is the Better Value Stock Right Now?

Zacks

4 days ago

PFE or LLY: Which Is the Better Value Stock Right Now?

Pfizer (PFE) Down 5% Since Last Earnings Report: Can It Rebound?

Zacks

4 days ago

Pfizer (PFE) Down 5% Since Last Earnings Report: Can It Rebound?

Pfizer and Arvinas gamble to shift breast cancer treatment paradigm

Clinical Trials Arena

4 days ago

Pfizer and Arvinas gamble to shift breast cancer treatment paradigm

Are Investors Undervaluing Pfizer (PFE) Right Now?

Zacks

4 days ago

Are Investors Undervaluing Pfizer (PFE) Right Now?

MT Newswires

4 days ago

Berenberg Bank Cuts Pfizer Price Target to $25 From $28, Maintains Hold Rating

With 67% ownership of the shares, Pfizer Inc. (NYSE:PFE) is heavily dominated by institutional owners

Simply Wall St.

5 days ago

With 67% ownership of the shares, Pfizer Inc. (NYSE:PFE) is heavily dominated by institutional owners

Is Pfizer Stock a Buy After This $1.25 Billion Investment?

Motley Fool

6 days ago

Is Pfizer Stock a Buy After This $1.25 Billion Investment?

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Zacks

6 days ago

Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It

Pfizer headquarters conversion project in Manhattan gets $720m loan

World Construction Network

6 days ago

Pfizer headquarters conversion project in Manhattan gets $720m loan

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer

Zacks

7 days ago

Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer

Junkiest Junk Is Offering a Warning Sign for Debt

Bloomberg

9 days ago

Junkiest Junk Is Offering a Warning Sign for Debt

Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost

Insider Monkey

9 days ago

Pfizer Inc. (PFE) Delivers Oncology Milestones with MesoC2 Debut and XTANDI Survival Boost

Down 63%, Should You Buy the Dip on Pfizer?

Motley Fool

9 days ago

Down 63%, Should You Buy the Dip on Pfizer?

Charting the Global Economy: Long-Term Bond Yields Soar Around the World

Bloomberg

9 days ago

Charting the Global Economy: Long-Term Bond Yields Soar Around the World

1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist

Motley Fool

9 days ago

1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

Motley Fool

9 days ago

U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result

Astellas Pharma and Pfizer’s Xtandi shows long-term survival in prostate cancer

TipRanks

10 days ago

Astellas Pharma and Pfizer’s Xtandi shows long-term survival in prostate cancer

Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication

Zacks

10 days ago

Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication

Pfizer (NYSE:PFE) Showcases New Cancer Treatment Study And Reports Prostate Cancer Drug Success

Simply Wall St.

10 days ago

Pfizer (NYSE:PFE) Showcases New Cancer Treatment Study And Reports Prostate Cancer Drug Success

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

Barrons.com

10 days ago

The New Covid-19 Jab Policy Wasn’t Up for Debate at the FDA’s Vaccine Meeting. Major Questions Remain.

Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More

Zacks

10 days ago

Pharma Stock Roundup: NVO CEO Resigns, SNY to Buy VIGL & More

Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial

Clinical Trials Arena

10 days ago

Astellas and Pfizer’s Xtandi combo reduces death risk in prostate cancer trial

MT Newswires

11 days ago

Pfizer, Astellas Pharma's Prostate Cancer Treatment Shows 30% Reduction in Risk of Death

Was Jim Cramer Right About Pfizer Inc. (PFE)?

Insider Monkey

11 days ago

Was Jim Cramer Right About Pfizer Inc. (PFE)?

Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer

PR Newswire

11 days ago

Astellas and Pfizer's XTANDI™ (enzalutamide) Shows Long-Term Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer

FDA panel recommends keeping COVID shots targeted to same strain as last year

BioPharma Dive

11 days ago

FDA panel recommends keeping COVID shots targeted to same strain as last year

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

Zacks

11 days ago

MRNA Stock Down on Withdrawal of FDA Filing for COVID-Flu Combo Shot

5 Low Price-to-Sales Stocks That Can Deliver Big Returns in 2025

Zacks

11 days ago

5 Low Price-to-Sales Stocks That Can Deliver Big Returns in 2025

Citi Maintains a Hold Rating on Pfizer (PFE) Amidst Pricing Policy Headwinds

Insider Monkey

12 days ago

Citi Maintains a Hold Rating on Pfizer (PFE) Amidst Pricing Policy Headwinds

Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal

Insider Monkey

12 days ago

Bernstein Reaffirms Pfizer Rating After $6B Cancer Treatment Deal

Home Depot backs outlook as U.S. sales ticked up: Morning Buzz

TipRanks

12 days ago

Home Depot backs outlook as U.S. sales ticked up: Morning Buzz

FDA to mandate trials for COVID boosters for healthy kids and adults

TipRanks

12 days ago

FDA to mandate trials for COVID boosters for healthy kids and adults

The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney

Zacks

12 days ago

The Zacks Analyst Blog Highlights Pfizer, Coca-Cola and The Walt Disney

MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots

Zacks

12 days ago

MRNA, PFE Stocks Jump Despite FDA's Stricter Standards for COVID-19 Shots

MT Newswires

12 days ago

Jefferies Adjusts Price Target on Pfizer to $33 From $32, Buy Rating Maintained

Giant US companies are rushing to Europe to borrow money

Bloomberg

12 days ago

Giant US companies are rushing to Europe to borrow money

2 High-Yield Dividend Stocks to Buy Right Now

Motley Fool

12 days ago

2 High-Yield Dividend Stocks to Buy Right Now

Stocks to Watch Recap: Home Depot, Tesla, Uber, UnitedHealth

The Wall Street Journal

13 days ago

Stocks to Watch Recap: Home Depot, Tesla, Uber, UnitedHealth

Trump's Drug Price War Could Slash Big Pharma Profits

GuruFocus.com

13 days ago

Trump's Drug Price War Could Slash Big Pharma Profits

BMO Capital Maintains Buy Rating on Pfizer (PFE) Stock

Insider Monkey

13 days ago

BMO Capital Maintains Buy Rating on Pfizer (PFE) Stock

COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers

Yahoo Finance Video

13 days ago

COVID vaccine guidelines, D-Wave, Viking Cruises: Trending Tickers

MT Newswires

13 days ago

Sector Update: Health Care Stocks Rise in Afternoon Trading

Does Pfizer (NYSE:PFE) Have A Healthy Balance Sheet?

Simply Wall St.

17 days ago

Does Pfizer (NYSE:PFE) Have A Healthy Balance Sheet?

Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income

Motley Fool

17 days ago

Here's How Many Shares of Pfizer You Should Own to Make $10,000 in Annual Dividend Income

House Pushes Pfizer on Vaccine Timing

GuruFocus.com

18 days ago

House Pushes Pfizer on Vaccine Timing

MT Newswires

18 days ago

Update: Market Chatter: US House Panel Says Ex-Pfizer Scientist Confirmed Involvement in Delaying COVID-19 Vaccine Results

MT Newswires

18 days ago

Market Chatter: US House Panel Says Ex-Pfizer Scientist Confirmed Involvement in Delaying COVID-19 Vaccine Results

New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel

The Wall Street Journal

18 days ago

New Allegations About Timing of Pfizer Covid Vaccine Passed to House Panel

5 Low Price-to-Book Value Stocks to Buy in May

Zacks

18 days ago

5 Low Price-to-Book Value Stocks to Buy in May

FDA delays approval decision for Biohaven rare disease drug

BioPharma Dive

18 days ago

FDA delays approval decision for Biohaven rare disease drug

3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever

Motley Fool

19 days ago

3 Magnificent S&P 500 Dividend Stocks Down 62%, 63%, and 64% to Buy and Hold Forever

Morningstar Research

19 days ago

Analyst Report: Pfizer Inc.

Jim Cramer on Pfizer (PFE) – “Caught in a Vortex, but I’m Sticking with Seagen and Dr. Bourla”

Insider Monkey

19 days ago

Jim Cramer on Pfizer (PFE) – “Caught in a Vortex, but I’m Sticking with Seagen and Dr. Bourla”

MT Newswires

19 days ago

EU Court Annuls Commission's Decision to Deny Access to Pfizer Texts With Von Der Leyen

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

Zacks

19 days ago

Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer

Court rules in favor of The New York Times over texts between the EU chief and a pharma boss

Associated Press Finance

19 days ago

Court rules in favor of The New York Times over texts between the EU chief and a pharma boss

Court annuls European Commission's refusal to disclose COVID texts

Reuters

19 days ago

Court annuls European Commission's refusal to disclose COVID texts

3 Value Stocks Facing Headwinds

StockStory

19 days ago

3 Value Stocks Facing Headwinds

Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom

Insider Monkey

20 days ago

Why Pfizer Inc. (PFE) Is Among the Best Pharma Stocks to Invest in Amid the Domestic Manufacturing Boom

PFE vs. LLY: Which Stock Is the Better Value Option?

Zacks

20 days ago

PFE vs. LLY: Which Stock Is the Better Value Option?

Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.

Barrons.com

20 days ago

Pfizer, Eli Lilly, and Other Pharma Stocks Fall. Questions Remain About Trump’s Executive Order.

Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared

Zacks

20 days ago

Drug Stocks Recover as Trump's Order Proves Not as Bad as Feared

PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline Productivity

StockStory

20 days ago

PFE Q1 Earnings Call: Revenue Misses, Margin Expansion, and Focus on Pipeline Productivity

Trump's drug price order is part request, part threat: Analyst

Yahoo Finance Video

21 days ago

Trump's drug price order is part request, part threat: Analyst

These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More

Barrons.com

21 days ago

These Stocks Moved the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, NRG Energy, Newmont, and More

How Trump could go about executing order to slash drug prices

Yahoo Finance Video

21 days ago

How Trump could go about executing order to slash drug prices

Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.

Barrons.com

21 days ago

Trump Executive Order Could Reshape How Americans Pay for Drugs. Why It Isn’t Bad for Pharma Stocks.

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

Yahoo Finance

21 days ago

Drug wars: Wall Street says big questions remain about impact of Trump's new pricing order

Trump expected to sign order to slash US drug prices

Yahoo Finance Video

21 days ago

Trump expected to sign order to slash US drug prices

US-China trade truce, April CPI, drug prices: 3 Things

Yahoo Finance Video

21 days ago

US-China trade truce, April CPI, drug prices: 3 Things

These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More

Barrons.com

21 days ago

These Stocks Are Moving the Most Today: Amazon, Nvidia, Tesla, Alibaba, Eli Lilly, Pfizer, RH, Newmont, and More

Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices

Barrons.com

21 days ago

Pfizer, Eli Lilly, Merck and Other Pharma Stocks Fall as Trump Targets Lower Drug Prices

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

Bloomberg

21 days ago

Trump’s Vow to Cut US Drug Prices Drags Pharma Stocks Lower

Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings

Simply Wall St.

21 days ago

Shareholders Will Be Pleased With The Quality of Pfizer's (NYSE:PFE) Earnings

MT Newswires

21 days ago

Pharma Shares Fall Pre-Bell Following Plan by Trump to Reduce US Prescription Drug Prices

Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.

Motley Fool

21 days ago

Wondering if Pfizer's 7.6% Dividend Yield Is Sustainable? Here's What You Need to Know.

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

Bloomberg

21 days ago

Pharmaceutical Stocks Tumble on Trump Plan to Cut US Drug Prices

Investors three-year losses continue as Pfizer (NYSE:PFE) dips a further 7.9% this week, earnings continue to decline

Simply Wall St.

23 days ago

Investors three-year losses continue as Pfizer (NYSE:PFE) dips a further 7.9% this week, earnings continue to decline

3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever

Motley Fool

23 days ago

3 Magnificent S&P 500 Dividend Stocks Down 30% to Buy and Hold Forever

Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?

Insider Monkey

23 days ago

Is Pfizer Inc. (PFE) the Best High-Yield Dividend Stock for 2025 and Beyond?

Are Your Mega-High Stock Dividends Safe?

Zacks

24 days ago

Are Your Mega-High Stock Dividends Safe?

Pfizer (PFE) Just Overtook the 20-Day Moving Average

Zacks

24 days ago

Pfizer (PFE) Just Overtook the 20-Day Moving Average

Was Jim Cramer Right About Pfizer (PFE)?

Insider Monkey

24 days ago

Was Jim Cramer Right About Pfizer (PFE)?

5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio

Zacks

24 days ago

5 Low Price-to-Sales Stocks That Deserve a Place in Your Portfolio

If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

Benzinga

25 days ago

If You Invested $10K In Pfizer Stock 10 Years Ago, How Much Would You Have Now?

A Look at Pharma ETFs After Strong Q1 Earnings

Zacks

25 days ago

A Look at Pharma ETFs After Strong Q1 Earnings

Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?

Zacks

25 days ago

Can Pfizer (PFE) Climb 25.14% to Reach the Level Wall Street Analysts Expect?

Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks

Motley Fool

25 days ago

Want $3,100 in Annual Dividends? Invest $18,000 in Each of These 3 Stocks

Share on Social Networks: